AzTrials
AzTrials

DepressionNCT05093816

Evaluating a Single-session Mental Health Intervention for UK University Students

A study testing Common Elements Toolbox in people with Depression and Anxiety, run by University of Pennsylvania.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The investigators are evaluating if an online single-session intervention, the Common Elements Toolbox (COMET) can improve mental health and wellbeing among UK university students. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Depression, Anxiety, Happiness
What is being tested?
Common Elements Toolbox
Could I receive a placebo?
No, everyone receives an active treatment
How many people
700 participants
Where
No sites listed yet
Study dates
20 Oct 2021to 1 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • At least 18 years old

Who cannot join

  • -

About this study

Official title: An Online Wellness Intervention for University Students: Investigating the Efficacy of The Common Elements Toolbox in the UK

The investigators are evaluating if an online single-session intervention, the Common Elements Toolbox (COMET) can improve mental health and wellbeing among UK university students.

Being tested
Common Elements Toolbox
Medical subject headings
Depression, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Common Elements ToolboxBehavioural

    The Common Elements Toolbox (COMET) is an online single-session intervention. It is entirely self-guided and lasts about 60 minutes. Participants complete a series of reading and writing exercises focused on four modules: cognitive restructuring, behavioral activation, gratitude, and self-compassion. The intervention is entirely unguided and completed in a single sitting.

Study groups in NCT05093816
Study groupRoleWhat they receive
Common Elements TooplboxExperimentalNot described
Receives: Behavioral: Common Elements Toolbox
Wait-list controlNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient Health Questionnaire-9 (PHQ-9)

    Measure of depressive symptoms. Scores range from 0-27, with higher scores indicating greater levels of depression.

    Measured: Change from baseline to four weeks post-intervention

  2. Generalized Anxiety Disorder 7-item Checklist (GAD-7)

    Measure of anxiety symptoms. Scores range from 0-21, with higher scores indicating greater levels of anxiety.

    Measured: Change from baseline to four weeks post-intervention

  3. Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS).

    Measure of wellbeing. Scores range from 7-35, with higher scores indicating greater well-being.

    Measured: Change from baseline to four weeks post-intervention

  4. Positive and Negative Affect Schedule

    A measure of positive affect and negative affect. Scores on the positive affect subscale range from 10-50, with higher scores indicating greater positive affect. The negative affect subscale also ranges from 10-50, with greater scores indicating greater levels of negative affect.

    Measured: Change from baseline to four weeks post-intervention

  5. Acceptability of Intervention Measure (AIM)

    Measure of acceptability. Scores range from 4-20, with higher scores indicating greater acceptability.

    Measured: Post-intervention (immediately after participants complete the intervention)

  6. Intervention Appropriateness Measure

    Measure of appropriateness. Scores range from 4-20, with higher scores indicating greater appropriateness.

    Measured: Post-intervention (immediately after participants complete the intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2021
  2. Study start20 Oct 2021 (estimated)
  3. Primary completion1 Oct 2022 (estimated)
  4. Study completion1 Sep 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
700 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05093816
Sponsor's protocol ID
21-212
Status last verified
Oct 2021
First submitted
1 Oct 2021
Last updated
28 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Common Elements Toolbox in people with Depression and Anxiety, run by University of Pennsylvania.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient Health Questionnaire-9 (PHQ-9) (time frame: Change from baseline to four weeks post-intervention). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in